腫瘍学腫瘍学バイオシミラーの世界市場レポート（2022年）

レポートナンバー　0000031751

腫瘍学腫瘍学バイオシミラーの世界市場レポート（2022年）

The Business Research Company

Oncology Biosimilars Global Market Report 2022

発刊日 2022/03/02

言語英語

体裁PDF/300ページ

ライセンス/価格300ページ

0000031751

Single	5,000USD
Site	7,500USD
Enterprise	10,000USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界の腫瘍学バイオシミラー市場を評価するために必要な重要な情報を提供します。

また、力強い成長を遂げている腫瘍学バイオシミラー市場に焦点を当てています。本レポートは、世界的なパンデミックという課題に対する市場の対応など、今後10年以上にわたって私たちの生活を形作り変化させる腫瘍学バイオシミラー市場へのガイドを提供します。

調査範囲

調査市場
➣ 薬剤タイプ別
　　◇ モノクローナル抗体
　　◇ 免疫調節剤
　　◇ 造血剤
　　◇ 顆粒球コロニー刺激因子（G-CSF）
➣ 癌のタイプ別
　　◇ 乳癌
　　◇ 結腸直腸癌
　　◇ 血液癌
　　◇ 好中球減少症癌
　　◇ 非小細胞肺癌
　　◇ その他
➣ 流通タイプ別
　　◇ 病院薬局
　　◇ 小売薬局
　　◇ オンライン薬局
調査企業
➣ Biocoin
➣ Celltrion Inc.
➣ Dr. Reddy's Laboratories Ltd.
➣ Intas Pharmaceuticals Ltd.
➣ STADA Arzneimittel AG
調査国
➣ ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、韓国、ロシア、イギリス、アメリカ、オーストラリア
調査地域
➣ アジア太平洋地域
➣ 西ヨーロッパ
➣ 東ヨーロッパ
➣ 北アメリカ
➣ 南アメリカ
➣ 中東
➣ アフリカ
調査期間
➣ 5年間の実績データおよび10年間の予測
データ
➣ 市場規模と成長率の関連市場に対する比率
➣ GDP比率
➣ 一人当たりの支出
データセグメント
➣ 国別・地域別の実績および予測データ
➣ 競合企業の市場シェア
➣ 市場セグメント
情報源および参照
➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

5. Oncology Biosimilars Market Size And Growth
5.1. Global Oncology Biosimilars Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Oncology Biosimilars Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Oncology Biosimilars Market Segmentation
6.1. Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Monoclonal Antibody
Immunomodulators
Hematopoietic Agents
Granulocyte Colony-Stimulating Factor (G-CSF)
6.2. Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Breast Cancer
Colorectal Cancer
Blood Cancer
Neutropenia Cancer
Non-Small Cell Lung Cancer
Others
6.3. Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

7. Oncology Biosimilars Market Regional And Country Analysis
7.1. Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Oncology Biosimilars Market
8.1. Asia-Pacific Oncology Biosimilars Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Oncology Biosimilars Market
9.1. China Oncology Biosimilars Market Overview
9.2. China Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Oncology Biosimilars Market
10.1. India Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Oncology Biosimilars Market
11.1. Japan Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Oncology Biosimilars Market
12.1. Australia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Oncology Biosimilars Market
13.1. Indonesia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Oncology Biosimilars Market
14.1. South Korea Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Oncology Biosimilars Market
15.1. Western Europe Oncology Biosimilars Market Overview
15.2. Western Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Oncology Biosimilars Market
16.1. UK Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Oncology Biosimilars Market
17.1. Germany Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Oncology Biosimilars Market
18.3. France Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Oncology Biosimilars Market
19.1. Eastern Europe Oncology Biosimilars Market Overview
19.2. Eastern Europe Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Oncology Biosimilars Market
20.1. Russia Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Oncology Biosimilars Market
21.1. North America Oncology Biosimilars Market Overview
21.2. North America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Oncology Biosimilars Market
22.1. USA Oncology Biosimilars Market Overview
22.2. USA Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Oncology Biosimilars Market
23.1. South America Oncology Biosimilars Market Overview
23.2. South America Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Oncology Biosimilars Market
24.1. Brazil Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Oncology Biosimilars Market
25.1. Middle East Oncology Biosimilars Market Overview
25.2. Middle East Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Oncology Biosimilars Market
26.1. Africa Oncology Biosimilars Market Overview
26.2. Africa Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Oncology Biosimilars Market Competitive Landscape And Company Profiles
27.1. Oncology Biosimilars Market Competitive Landscape
27.2. Oncology Biosimilars Market Company Profiles
27.2.1. Biocoin
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Celltrion Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Dr. Reddy's Laboratories Ltd.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Intas Pharmaceuticals Ltd.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. STADA Arzneimittel AG
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Oncology Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Oncology Biosimilars Market

30. Oncology Biosimilars Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: China, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: India, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: Japan, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Australia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: Indonesia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: South Korea, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Western Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: UK, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Germany, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: France, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Eastern Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Russia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: North America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: USA, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: South America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: Brazil, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Middle East, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Africa, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Biocoin Financial Performance
Table 28: Celltrion Inc. Financial Performance
Table 29: Dr. Reddy's Laboratories Ltd. Financial Performance
Table 30: Intas Pharmaceuticals Ltd. Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Oncology Biosimilars Market, Segmentation By Cancer Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Oncology Biosimilars Market, Segmentation By Distribution Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Oncology Biosimilars Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Oncology Biosimilars Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: China, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: India, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: Japan, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Australia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: Indonesia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: South Korea, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Western Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: UK, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Germany, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: France, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Eastern Europe, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Russia, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: North America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: USA, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: South America, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: Brazil, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Middle East, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Africa, Oncology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Biocoin Financial Performance
Figure 28: Celltrion Inc. Financial Performance
Figure 29: Dr. Reddy's Laboratories Ltd. Financial Performance
Figure 30: Intas Pharmaceuticals Ltd. Financial Performance
Figure 31: STADA Arzneimittel AG Financial Performance

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000031751

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。